Q4 2020 Spero Therapeutics Inc Earnings Call Transcript
Greetings, and welcome to Spero Therapeutics Fourth Quarter and Full Year 2020 Financial Results Call. (Operator Instructions).
As a reminder, this conference is being recorded. It is now my pleasure to introduce your host for today's call, Sharon Klahre. Thank you. You may begin.
Great. Thank you, operator, and thank you all for participating in today's conference call. Earlier today, Spero Therapeutics released financial results and provided a pipeline update for the fourth quarter and full year 2020. If you have not yet seen the press release, it's available on the Investor page of the Spero Therapeutics website.
Before I begin, I'd like to remind you that some of the information contained in the press release and on this conference call contain forward-looking statements based on our current expectations. Including statements about the initiation, timing and submission to the FDA of the NDA for tebipenem HBr and the potential approval of tebipenem HBr by the FDA,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
